Herpes Zoster Vaccine

    Efficacy, effectiveness, and safety of herpes zoster vaccines in individuals aged 50 years of age and older: a systematic review


    • The review aims to assess the efficacy, effectiveness, and safety of the herpes zoster (HZ) live vaccine compared to the HZ subunit vaccine or placebo/no intervention for individuals aged 50 years and older
    • Conducted for the National Advisory Committee on Immunization Secretariat and Herpes Zoster Working Group to inform their recommendations on herpes zoster vaccination



    Canadian Institutes of Health Research (CIHR)/ Drug Safety and Effectiveness Network (DSEN)

    Category :

    Date : 31 Oct 2017